Premium
Commentary: BRAF inhibitors for metastatic melanoma
Author(s) -
Marples M.
Publication year - 2013
Publication title -
british journal of dermatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.12240
Subject(s) - vemurafenib , dabrafenib , medicine , melanoma , dacarbazine , clinical endpoint , oncology , trametinib , metastatic melanoma , context (archaeology) , clinical trial , cancer research , kinase , mapk/erk pathway , biology , paleontology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom